ADL
FLGT icon

Asset Dedication LLC’s Fulgent Genetics FLGT Stock Holding History

Asset Dedication LLC’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,431
Closed -$31.1K – 1122
2024
Q3 		$31.1K Sell
1,431
-240
-14% -$5.37K ﹤0.01% 591
2024
Q2 		$32.8K Buy
+1,671
New +$34.9K ﹤0.01% 567
2021
Q4 		– Sell
-136
Closed -$12K – 960
2021
Q3 		$12K Hold
136
– – ﹤0.01% 654
2021
Q2 		$13K Buy
+136
New +$10.9K ﹤0.01% 581

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Asset Dedication LLC's FLGT Position: Q4 2024 in Review

Asset Dedication LLC sold out of Fulgent Genetics (FLGT) in Q4 2024, closing a stake of 1,431 shares — an estimated $31.1K sold.

Asset Dedication LLC first reported a position in FLGT in Q2 2021 and held it in 4 quarters. The position peaked at $32.8K in Q2 2024. 189 funds tracked by Wall St. Rank hold FLGT as of Q4 2024.

  • Asset Dedication LLC reported no remaining Fulgent Genetics position as of Q4 2024 after selling out during the quarter.
  • Asset Dedication LLC sold 1,431 Fulgent Genetics shares in Q4 2024, an estimated $31.1K.
  • Asset Dedication LLC first reported a position in Fulgent Genetics in Q2 2021 and held it in 4 quarters.
  • Asset Dedication LLC's Fulgent Genetics position peaked at $32.8K in Q2 2024.
  • 189 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2024.

Based on Asset Dedication LLC's 13F filing for Q4 2024, filed 23 Jan 2025.